Difference between revisions of "Roux-en-Y gastric bypass"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
==General== | ==General== | ||
*Treatment for [[obesity]]. | *Treatment for [[obesity]]. | ||
*Mortality ~0.15%.<ref name=pmid23470583>{{Cite journal | last1 = Benotti | first1 = P. | last2 = Wood | first2 = GC. | last3 = Winegar | first3 = DA. | last4 = Petrick | first4 = AT. | last5 = Still | first5 = CD. | last6 = Argyropoulos | first6 = G. | last7 = Gerhard | first7 = GS. | title = Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. | journal = Ann Surg | volume = 259 | issue = 1 | pages = 123-30 | month = Jan | year = 2014 | doi = 10.1097/SLA.0b013e31828a0ee4 | PMID = 23470583 }} | |||
</ref> | |||
==Sign out== | ==Sign out== | ||
Revision as of 23:42, 2 May 2018
Roux-en-Y gastric bypass is procedure used to treat obesity.
General
Sign out
Small Bowel, Excision During Gastric Bypass:
- Small bowel wall within normal limits.
Small Bowel, Excision during Roux-en-Y Gastric Bypass: - Small bowel wall within normal limits.
See also
- ↑ Benotti, P.; Wood, GC.; Winegar, DA.; Petrick, AT.; Still, CD.; Argyropoulos, G.; Gerhard, GS. (Jan 2014). "Risk factors associated with mortality after Roux-en-Y gastric bypass surgery.". Ann Surg 259 (1): 123-30. doi:10.1097/SLA.0b013e31828a0ee4. PMID 23470583.